The global vendor neutral archive and pacs market size is calculated at USD 4.44 billion in 2025 and is forecasted to reach around USD 10.53 billion by 2034, accelerating at a CAGR of 10.80% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Vendor Neutral Archive and PACS Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Vendor Neutral Archive and PACS Market, by Imaging Modality
8.1.1. X-Ray
8.1.1.1. Market Revenue and Forecast
8.1.2. Computed Tomography
8.1.2.1. Market Revenue and Forecast
8.1.3. Magnetic Resonance Imaging
8.1.3.1. Market Revenue and Forecast
8.1.4. Ultrasound
8.1.4.1. Market Revenue and Forecast
8.1.5. Nuclear Imaging
8.1.5.1. Market Revenue and Forecast
9.1. Vendor Neutral Archive and PACS Market, by End-user
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast
9.1.2. Diagnostic Imaging Centers
9.1.2.1. Market Revenue and Forecast
9.1.3. Ambulatory Surgical Centers
9.1.3.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Imaging Modality
10.1.2. Market Revenue and Forecast, by End-user
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Imaging Modality
10.1.3.2. Market Revenue and Forecast, by End-user
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Imaging Modality
10.1.4.2. Market Revenue and Forecast, by End-user
10.2. Europe
10.2.1. Market Revenue and Forecast, by Imaging Modality
10.2.2. Market Revenue and Forecast, by End-user
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Imaging Modality
10.2.3.2. Market Revenue and Forecast, by End-user
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Imaging Modality
10.2.4.2. Market Revenue and Forecast, by End-user
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Imaging Modality
10.2.5.2. Market Revenue and Forecast, by End-user
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Imaging Modality
10.2.6.2. Market Revenue and Forecast, by End-user
10.3. APAC
10.3.1. Market Revenue and Forecast, by Imaging Modality
10.3.2. Market Revenue and Forecast, by End-user
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Imaging Modality
10.3.3.2. Market Revenue and Forecast, by End-user
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Imaging Modality
10.3.4.2. Market Revenue and Forecast, by End-user
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Imaging Modality
10.3.5.2. Market Revenue and Forecast, by End-user
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Imaging Modality
10.3.6.2. Market Revenue and Forecast, by End-user
10.4. MEA
10.4.1. Market Revenue and Forecast, by Imaging Modality
10.4.2. Market Revenue and Forecast, by End-user
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Imaging Modality
10.4.3.2. Market Revenue and Forecast, by End-user
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Imaging Modality
10.4.4.2. Market Revenue and Forecast, by End-user
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Imaging Modality
10.4.5.2. Market Revenue and Forecast, by End-user
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Imaging Modality
10.4.6.2. Market Revenue and Forecast, by End-user
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Imaging Modality
10.5.2. Market Revenue and Forecast, by End-user
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Imaging Modality
10.5.3.2. Market Revenue and Forecast, by End-user
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Imaging Modality
10.5.4.2. Market Revenue and Forecast, by End-user
11.1. Merge Healthcare Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Visage Imaging
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Xerox Corporation
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. GE Healthcare
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Caresyntax AG
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Canon Medical Systems
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Soft Imaging Systems
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Cerner Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Advanced Imaging Concepts
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Fujifilm Holdings Corporation
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample